ConductScience.org, home

Paper31325035

MicroRNAs: Key Players in Bladder Cancer.

Li Q and 7 others. Mol Diagn Ther, 2019. Cited by 40 papers, by iCite.

Cite this record

ConductScience Library. MicroRNAs: Key Players in Bladder Cancer. Papers, record 31325035. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/31325035

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
MicroRNAs: Key Players in Bladder Cancer.
PubMed
Journal
Mol Diagn Ther
PubMed
Year
2019
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Review
PubMed
Citations, by iCite
40
iCite
Relative citation ratio, by iCite
1.73
iCite
Revised in PubMed
2020-05-07
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Li QQihttps://orcid.org/0000-0003-4031-8120
2Wang HHelei
3Peng HHourong
4Huang QQiuping
5Huyan TTing
6Huang QQingsheng
7Yang HHui
8Shi JJunling

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Biomarkers, TumorMajor topic
Gene Expression Regulation, NeoplasticMajor topic
MicroRNAsMajor topic
Urinary Bladder NeoplasmsMajor topic
Exosomes
Humans
Molecular Diagnostic Techniques
Neoplasm Grading
Neoplasm Staging
Prognosis
RNA Interference

Source PubMed

Download CSV of topics

References203

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
126905370Intravesical treatment of advanced urothelial bladder cancers with oncolytic HSV-1 co-regulated by differentially expressed microRNAs.Gene Ther2016https://conductscience.org/library/papers/26905370PubMed
230654976Measurement of Urinary Level of a Specific Competing endogenous RNA network (FOS and RCAN mRNA/ miR-324-5p, miR-4738-3p, /lncRNA miR-497-HG) Enables Diagnosis of Bladder Cancer.Urol Oncol2019https://conductscience.org/library/papers/30654976PubMed
327429046Up-regulation of p16 by miR-877-3p inhibits proliferation of bladder cancer.Oncotarget2016https://conductscience.org/library/papers/27429046PubMed
422361633Hedgehog pathway activation in human transitional cell carcinoma of the bladder.Br J Cancer2012https://conductscience.org/library/papers/22361633PubMed
526036261Intravesical administration of exogenous microRNA-145 as a therapy for mouse orthotopic human bladder cancer xenograft.Oncotarget2015https://conductscience.org/library/papers/26036261PubMed
622265971MicroRNA-195-5p suppresses glucose uptake and proliferation of human bladder cancer T24 cells by regulating GLUT3 expression.FEBS Lett2012https://conductscience.org/library/papers/22265971PubMed
728938585The trophoblast cell surface antigen 2 and miR-125b axis in urothelial bladder cancer.Oncotarget2017https://conductscience.org/library/papers/28938585PubMed
825884322MiRNA-141 and miRNA-200b are closely related to invasive ability and considered as decision-making biomarkers for the extent of PLND during cystectomy.BMC Cancer2015https://conductscience.org/library/papers/25884322PubMed
919074842MicroRNAs and cancer: past, present, and potential future.Mol Cancer Ther2008https://conductscience.org/library/papers/19074842PubMed
1019116145Epigenetic therapy upregulates the tumor suppressor microRNA-126 and its host gene EGFL7 in human cancer cells.Biochem Biophys Res Commun2009https://conductscience.org/library/papers/19116145PubMed
1111157775RNA interference is mediated by 21- and 22-nucleotide RNAs.Genes Dev2001https://conductscience.org/library/papers/11157775PubMed
1223677384Decreased expression of miR-430 promotes the development of bladder cancer via the upregulation of CXCR7.Mol Med Rep2013https://conductscience.org/library/papers/23677384PubMed
1323741253miR-96 regulates FOXO1-mediated cell apoptosis in bladder cancer.Oncol Lett2012https://conductscience.org/library/papers/23741253PubMed
1425168920Urinary cell-free microRNA-106b as a novel biomarker for detection of bladder cancer.Med Oncol2014https://conductscience.org/library/papers/25168920PubMed
1527099514Repression of the miR-93-enhanced sensitivity of bladder carcinoma to chemotherapy involves the regulation of LASS2.Onco Targets Ther2016https://conductscience.org/library/papers/27099514PubMed
1624823697MicroRNA-126 inhibits invasion in bladder cancer via regulation of ADAM9.Br J Cancer2014https://conductscience.org/library/papers/24823697PubMed
1723863690Extracellular microRNAs in urologic malignancies: chances and challenges.Int J Mol Sci2013https://conductscience.org/library/papers/23863690PubMed
1825498275Micro RNA expression and prognosis in low-grade non-invasive urothelial carcinoma.Int Braz J Urol2014https://conductscience.org/library/papers/25498275PubMed
1927468885MicroRNAs in urine supernatant as potential non-invasive markers for bladder cancer detection.Neoplasma2016https://conductscience.org/library/papers/27468885PubMed
2029363887Genome-wide identification of urinary cell-free microRNAs for non-invasive detection of bladder cancer.J Cell Mol Med2018https://conductscience.org/library/papers/29363887PubMed

See all 203 referencesDownload CSV of references

Cited by29

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 40 citations.

PMIDTitleJournalYearIn PapersSource
42793039Evaluation of Candidate Urinary microRNAs in Upper Tract Urothelial Carcinoma: A Prospective Multicenter Biomarker Study (JCOG1403A1).Genes (Basel)2026https://conductscience.org/library/papers/42793039PubMed
41438986Molecular mechanisms and translational advances in bladder cancer: from driver genes to precision therapy.Front Oncol2025https://conductscience.org/library/papers/41438986PubMed
41252049Utilizing a novel mitochondrial-related gene signature for predicting the prognosis and immunological impact in bladder cancer.Discov Oncol2025https://conductscience.org/library/papers/41252049PubMed
40937200miR-145-Mediated Tumor Suppression in Bladder Urothelial Carcinoma via Targeting the ADAMTS5/Wnt Signaling Axis.Cureus2025https://conductscience.org/library/papers/40937200PubMed
401245702'-Hydroxyflavanone inhibits bladder cancer cell proliferation and angiogenesis via regulating miR-99a-5p/mTOR signaling.Am J Clin Exp Urol2025https://conductscience.org/library/papers/40124570PubMed
39903549Innovative logic "AND" gate gene circuits for bladder cancer treatment: preclinical study.Int J Surg2025https://conductscience.org/library/papers/39903549PubMed
39041274ADAMTS16 Suppression by MicroRNA-25 Leads to Oncogenic Properties in Renal Cell Carcinoma.Comb Chem High Throughput Screen2025https://conductscience.org/library/papers/39041274PubMed
37715207Targeting FGFRs by pemigatinib induces G1 phase cell cycle arrest, cellular stress and upregulation of tumor suppressor microRNAs.J Transl Med2023https://conductscience.org/library/papers/37715207PubMed
37092087MicroRNA-186 suppresses cell proliferation and metastasis in bladder cancer.Afr Health Sci2022https://conductscience.org/library/papers/37092087PubMed
36499501miR-221-5p and miR-186-5p Are the Critical Bladder Cancer Derived Exosomal miRNAs in Natural Killer Cell Dysfunction.Int J Mol Sci2022https://conductscience.org/library/papers/36499501PubMed
35403137Bladder Cancer-related microRNAs With In Vivo Efficacy in Preclinical Models.Cancer Diagn Progn2021https://conductscience.org/library/papers/35403137PubMed
35004679Non-Coding RNA m6A Modification in Cancer: Mechanisms and Therapeutic Targets.Front Cell Dev Biol2021https://conductscience.org/library/papers/35004679PubMed
34988018Identification and Validation of Hub Genes Associated with Bladder Cancer by Integrated Bioinformatics and Experimental Assays.Front Oncol2021https://conductscience.org/library/papers/34988018PubMed
34659560MiR-25 regulates cell proliferation and metastasis in bladder urothelial carcinoma.J Cancer2021https://conductscience.org/library/papers/34659560PubMed
33997007Urinary Angiogenin as a Marker for Bladder Cancer: A Meta-Analysis.Biomed Res Int2021https://conductscience.org/library/papers/33997007PubMed
33973417Exosomes in bladder cancer: novel biomarkers and targets.J Zhejiang Univ Sci B2021https://conductscience.org/library/papers/33973417PubMed
33846791Propofol modulates the proliferation, invasion and migration of bladder cancer cells through the miR‑145‑5p/TOP2A axis.Mol Med Rep2021https://conductscience.org/library/papers/33846791PubMed
33833571circCEP128 Knockdown Suppresses Bladder Cancer Progression via Regulating microRNA-515-5p/SDC1 Axis.Cancer Manag Res2021https://conductscience.org/library/papers/33833571PubMed
33312391Clinical effects and molecular mechanisms of lncRNA MNX1-AS1 in malignant tumors.Am J Transl Res2020https://conductscience.org/library/papers/33312391PubMed
33221743DNMT3B silencing suppresses migration and invasion by epigenetically promoting miR-34a in bladder cancer.Aging (Albany NY)2020https://conductscience.org/library/papers/33221743PubMed

See all 29 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/31325035

GET https://conductscience.org/api/papers/v1/31325035/references?page=2